Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 02/19/25
Unlocking Q4 Potential of Bausch + Lomb (BLCO): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 02/17/25
Aehr Test Systems Posts Weak Results, Joins Trump Media & Technology Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga • 01/14/25
Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 10/30/24
Bausch + Lomb (BLCO) Surges 14.5%: Is This an Indication of Further Gains?Zacks Investment Research • 09/17/24
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?Investors Business Daily • 09/16/24
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 CongressBusiness Wire • 06/17/24
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United StatesBusiness Wire • 06/10/24
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United StatesBusiness Wire • 06/03/24
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting®Business Wire • 05/28/24
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular LensBusiness Wire • 05/28/24